Sector
PharmaceuticalsOpen
₹570.15Prev. Close
₹570.15Turnover(Lac.)
₹194.19Day's High
₹588.05Day's Low
₹564.352 Week's High
₹937.9552 Week's Low
₹510.2Book Value
₹349.06Face Value
₹2Mkt Cap (₹ Cr.)
4,128.24P/E
25.91EPS
22.64Divi. Yield
0Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.
Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.
According to the corporation, the observations have no influence on business continuity or supplies to the US market.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 14.08 | 14.08 | 14.08 | 14.08 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,280.54 | 2,370.19 | 2,657.96 | 2,683.25 |
Net Worth | 2,294.62 | 2,384.27 | 2,672.04 | 2,697.33 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 942.92 | 1,123.97 | 904.88 | 669.33 |
yoy growth (%) | -16.1 | 24.21 | 35.19 | 16.19 |
Raw materials | -383.47 | -432.94 | -382.75 | -350.68 |
As % of sales | 40.66 | 38.51 | 42.29 | 52.39 |
Employee costs | -250.79 | -234.03 | -205.15 | -146.53 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -86.74 | 65.64 | -63.81 | -121.55 |
Depreciation | -83.18 | -75.89 | -71.08 | -45.04 |
Tax paid | 31.31 | -11.56 | 7.49 | 0.14 |
Working capital | 139.57 | -55.07 | -268.15 | 642.72 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -16.1 | 24.21 | 35.19 | 16.19 |
Op profit growth | -145.62 | -205.35 | -33.48 | 134.8 |
EBIT growth | -226.48 | -207.06 | -47.18 | 31.19 |
Net profit growth | -202.49 | -196.03 | -102.2 | 2,361.41 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 2,110.97 | 1,785.11 | 1,343.02 | 1,269.83 | 1,235.14 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,110.97 | 1,785.11 | 1,343.02 | 1,269.83 | 1,235.14 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 35.32 | 31.59 | 38.52 | 47.51 | 50.19 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Non Exe. Director
Priti Puri
Non-Exec & Non-Independent Dir
Pranay Godha
Managing Director
Pabitra Bhattacharya
Company Sec. & Compli. Officer
Pradeep Bhandari
Chairman (Non-Executive)
Prakash A Mody
Independent Director
Anand T Kusre
Independent Director
Arun Todarwal
Unichem Bhavan Prabhat Estate,
Off S V Road Jogeshwari (West),
Maharashtra - 400102
Tel: 91-22-66888333
Website: http://www.unichemlabs.com
Email: shares@unichemlabs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Unichem Laboratories Limited is an India-based pharmaceutical company, which manufactures active pharmaceutical ingredients. The company operates through four divisions, namely Unichem Pharma Division...
Read More
Reports by Unichem Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.